Skip to main content

Home/ MaRS/ Group items tagged B

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Assunta Krehl

Go to MaRS - Canadian Newcomers Magazine - 0 views

74.125.77.132/search

stories KCT Clera

shared by Assunta Krehl on 14 Aug 09 - Cached
  • nd development of new ideas. It provides not only office and lab space but also free mentoring assistance to new businesses in science, technology and social innovation. While there are probably no chickens hatching at MaRS, it wouldn't be at all surprising to find a company working on, say, a vaccine for bird flu. Approximately 20 incubator companies are currently housed at MaRS, including Clera Inc. - which is developing treatments for schizophrenia and depression; AXS Biomedical Animations Studio - a company that creates 3D medical animation for biomedical research and other applications; and Kanata Chemical Technologies (KCT), which has had great success developing catalysts for the chemical industry (catalysts speed up chemical reactions without being changed or consumed in those reactions
  • All of the above definitions could apply to the wider innovation community connected with the MaRS Centre. Located in the heart of Toronto's Discovery District - a 2.5 sq. kilometre downtown research district, MaRS is a non-profit environment for the birt
  • KCT founder and president Kamal Abdur-Rashid came to Canada in 1997 with a degree from the University of the West Indies
  • ...5 more annotations...
  • With support from the Mississauga Technology Business Accelerator (MTBA) he started his business, which grew to occupy some state-of-the-art labs at MaRS and is about to take the next step forward by moving its business outside of the protecting and nurturing environment of MaRS. This is the entire purpose of MaRS, which says on its website (www.marsdd.com), "We measure our success through the companies that emerge after receiving help from MaRS." "The resources, the facilities, the training and everything else that MaRS is bringing to the table - we're able to capitalize on that and get off on a very solid footing," says Kamal. Inside the Incubato
  • Whether you're looking for work - or you want to start your own business, MaRS is one of the best places to start your search.
  • Everybody you talk to in the elevator, the hall, the cafeteria - they are all in the science field - so you can network with one another," says Ratheesh. "MaRS does not just provide research space, they are bringing business people, people with money." These are the connections that can turn your idea into a profit-making business that employs many people. This is exactly what MaRS is all about. As they say on their website, "MaRS connects the communities of science, business and capital and fosters collaboration among them." MaRS advisors are able to connect entrepreneurs with private funding opportunities as well as free educational programming and hands-on advisory services. Corporate sponsor CIBC funds an entrepreneurship lecture series, for example. Ratheesh adds, "Patent people are here as well, so if you have patentable technology, you can talk to them." Once you start your business, MaRS offers many supports. "When we had the lab space we had the chemical hood that had to be set up so MaRS came and provided people to set up our hood," explains Ratheesh. "They help us dispose of chemical waste, provide water service, fridge and freezer service - so these are all important. "For smaller companies that have problem buying fridges and freezers, they can use common equipment." MaRS facilities also include lecture theatres, meeting rooms and an auditorium. Growing Cultures Bacteria and tissue cultures aren't the only cultures that thrive in the MaRS environment. It's also a great place for newcomers from every culture to
  • Clera, one of many emerging companies housed in the MaRS incubator.
  • He says, "MaRS is a one-stop shop for job and information seekers. Here we have many companies - so quite a few job opportunities
  • Assunta Krehl on 14 Aug 09
     
    A look at Canadian immigrants who started a business and are incubating at the MaRS Centre. KCT and Clera, MaRS Tenants tell their stories. Jan/Feb 2009
  • Assunta Krehl on 14 Aug 09
     
    A look at Canadian immigrants who started a business and are incubating at the MaRS Centre. KCT and Clera, MaRS Tenants tell their stories.
Assunta Krehl

Bullfrog Power(R) Becomes One of Canada's First Certified B Corporations - Marketwire -... - 0 views

www.marketwire.com/...ied-b-corporations-1598402.htm

Bullfrog Power MaRS B Corporate social impact

shared by Assunta Krehl on 22 Dec 11 - No Cached
  • Assunta Krehl on 22 Dec 11
     
    Bullfrog Power received certification as one of Canada's Founding B Corporations by B Lab, a nonprofit organization working to build a community of socially and environmentally conscious businesses. The Centre for Impact Investing has a partnership with B Lab, acting as the Canadian Certified B Corp Hub.
Assunta Krehl

Canadian 'B Corps' Put Their Money Where Their Branding Is On Social Causes - The Huffi... - 1 views

www.huffingtonpost.ca/...it-corporations_n_1251383.html

social entreneurship advisor Allyson Hewitt B Corp impact investing SiG Social Innovation Generation

shared by Assunta Krehl on 10 Feb 12 - No Cached
  • Assunta Krehl on 10 Feb 12
     
    Rachel Mendleson states "A growing number of Canadian companies are now becoming certified as "B Corps," a new designation that seeks to distinguish firms that are committed to improving more than their bottom line." Allyson Hewitt, director of social entrepreneurship, MaRS Discovery District states that "MaRS is at the forefront of the Canadian B Corp movement."
Assunta Krehl

Research from P.B. Stathopulos and colleagues has provided new data on biological chemi... - 0 views

www.highbeam.com/...1G1-194834212.html

Diagnostics and Imaging

shared by Assunta Krehl on 13 Aug 09 - Cached
  • Assunta Krehl on 13 Aug 09
     
    Research from P.B. Stathopulos and colleagues has provided new data on biological chemistry.
  • Assunta Krehl on 13 Aug 09
     
    Research from P.B. Stathopulos and colleagues has provided new data on biological chemistry. March 6, 2009
Sarah Hickman

The Well-Designed Global R&D Network - 0 views

www.strategy-business.com/...rr00032

commercialization research*&*development globalization innovation

shared by Sarah Hickman on 14 Aug 09 - Cached
  • Sarah Hickman on 14 Aug 09
     
    Consider the two faces of the global innovation movement. Company A, having grown through acquisition, produces multiple brands for multiple markets and operates a worldwide network of research and product development centers. Each of its R&D sites was initially responsible for its own brands and local market, but with globalization these distinctions have lost their importance. Company B, on the other hand, was built largely through internal growth and has two global brands. It operates one primary R&D center supported by a handful of special-purpose sites around the world. This comparatively sparse network has helped Company B win wide admiration for the efficiency of its engineering. Because expanding the number of nodes in a network exponentially increases its complexity, it is not surprising that Company A's R&D structure is more expensive to operate. Company A has considered closing some sites, but has resisted doing so because it fears losing capabilities and insights, and roiling local markets. Meanwhile, incremental budget cuts have chipped away at engineer and supplier morale. Having built its network to maximize the value associated with market access, it is now forced to manage the network for cost. Most global innovation networks look like Company A's - and suffer the same problems. Company B's R&D structure is clearly more productive, but it is not necessarily ideal either. Its network might be too compact, limiting access to knowledge that could maximize performance. Thus, to identify principles and practices for creating a truly well-designed innovation network, Booz Allen Hamilton and INSEAD, the international business school, surveyed R&D leaders in 186 companies from 17 industry sectors in 19 nations in 2005. The survey results, and our own experience, suggest one central truth: Organizations benefit when they configure their innovation networks for cost and manage them for value.
Assunta Krehl

TMX Group confirms support for impact investing - Advisor.ca - December 14, 2011 - 0 views

www.advisor.ca/...ort-for-impact-investing-67863

B Corporations MaRS The Centre for Impact Investing social finance

shared by Assunta Krehl on 22 Dec 11 - No Cached
  • Assunta Krehl on 22 Dec 11
     
    Melissa Shin, Advisor.ca reporter states "Toronto is now home to the world's first non-U.S.-based hub for B Corporations, or companies that use the power of business to solve social and environmental problems.   The hub will be hosted at the MaRS Discovery District as part of the Centre for Impact Investing, which officially launched December 13."
Assunta Krehl

Online fundraising innovator named Canada's first certified B Corporation - a new corpo... - 0 views

www.canadanewswire.ca/...c7427.html

Social Innovation Social Entrepreneurship Betther the World Ogilvy Renault Advisors Allyson Hewitt

shared by Assunta Krehl on 01 Dec 09 - Cached
  • Assunta Krehl on 01 Dec 09
     
    Better the World Inc., a novel for-profit online fundraising platform, has been named Canada's first certified "B Corporation". Mention of MaRS working with Better The World to chart their progress and ensure other companies could benefit from their experience in gaining this designation through the support of a pro bono legal team from Carters Professional Corporation, Ogilvy Renault and Blake, Cassels & Graydon. March 11, 2009
Karen Schulman Dupuis

Women 2.0 » B-Corp Squag Helps Autistics Kids Communicate - With A Revenue Mo... - 0 views

www.women2.com/lps-autistics-kids-communicate

clients Squag socialentrepreneurship social

shared by Karen Schulman Dupuis on 28 May 12 - No Cached
  • Karen Schulman Dupuis on 28 May 12
     
    Winter launched Squag, a social space for children with autism or those who communicate differently. For the past 11 years, she has worked as an aide to her austistic nephew, who she calls spectacular and the strongest person she knows. Kids like him are totally underestimated, she says, which compelled her to build Squag to help them express themselves and communicate - in an almost artist-like way - as well as develop friendship and connection.
Assunta Krehl

Morgan Solar Inc. Closes B Round at USD $28.8 Million, with USD $9.8 Million Investment... - 0 views

www.prnewswire.com/...om-enbridge-inc-134666503.html

Clients Morgan Solar cleantech funding

shared by Assunta Krehl on 03 Dec 11 - No Cached
  • Assunta Krehl on 03 Dec 11
     
    Morgan Solar a MaRS Client announced that it has secured a USD $9.8 million (CAD $10 million) investment from Enbridge Inc.
Assunta Krehl

Time to build the Toronto of Tomorrow - The Star - 0 views

74.125.95.132/search

MaRS

shared by Assunta Krehl on 27 Aug 09 - Cached
  • Other successes of the past year include the creation of the MaRS Discovery District, a new centre on University Ave. that focuses on commercializing biomedical research, and the Toronto Waterfront Revitalization Corp., he said
  • Assunta Krehl on 27 Aug 09
     
    According the Toronto Star, Dale Richmond states that he "believes it is a perfect time to lobby Ottawa and Queen's Park for Toronto's needs. Successes of the past include the MaRS project that focuses on commercializing biomedical research."
  • Assunta Krehl on 27 Aug 09
     
    According the Toronto Star, Dale Richmond states that he believe it is a perfect time to lobby Ottawa and Queen's Park for Toronto's needs. Successes of the past include the MaRS project that focuses on commercializing biomedical research. Jan 23, 2003
Assunta Krehl

Changing Colours - BizBash - 0 views

216.213.87.98/story_print2.php

MaRS Italian Trade Commisson Toronto International Film Festival

shared by Assunta Krehl on 18 Sep 09 - Cached
  • Film Italia and the Italian Trade Commission's annual TIFF party took on a  chameleon theme set at the MaRS Discovery Centre.
  • The lower-key festival event, held at the MaRS Discovery District, attracted more than 400 people and took on a chameleon theme and slogan: "Try on the colours of Italian cinema."
  • “We try every year to shock people and to be a novelty,” said Italian trade commissioner Paolo Ponti of the party, which he planned in collaboration with Graham. Ponti said MaRS was chosen as a venue this year because of its melding of old and new and its representation of innovation. (The centre is known for leadership in science and business research.)
  • ...2 more annotations...
  • The Italian Trade Commission chose MaRS as a venue for this year's TIFF party to represent innovation.
  • Rentals, Venue MaRS Discovery District
  • Assunta Krehl on 18 Sep 09
     
    The Italian Trade Commission's Annual TIFF party was held at the MaRS Centre. More than 400 people attended the event. Sept 18, 2009
Assunta Krehl

Pharmafocus.com - 0 views

www.pharmafocus.com/...eature_detail-0-493032,00.html

Canada collaboration discovery district entrepreneur science technology Ilse Treurnicht AstraZeneca GlaxoSmithline MaRS Innovation Primaxis Transition Therapeutics Rafi Hofstein convergence stem cell nitric oxide

shared by Assunta Krehl on 04 Aug 09 - Cached
  • Canada has always had to fight hard to attract talent and investment
  • MaRS Vital to Toronto's life sciences vision is MaRS (derived from Medical and Related Sciences) a non-profit organisation and business centre located in the heart of the city. Its core function is as a biotech incubator and business park, known as MaRS Discovery District. The venture was first established in 2000 to help foster and accelerate the growth of successful Canadian businesses and, after some uncertain times, it is now gathering momentum. A separate technology transfer office, MaRS Innovation, has also been established that, it is hoped, can be a world beater in its own right (see Turning good ideas into world beaters below). The location of the MaRS building in central Toronto is important, as it is just a stone's throw away from an existing cluster of universities and academic hospitals. MaRS has many links with other research-based organisations, including collaborations with three local universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS occupies the Old Toronto general hospital, where insulin was first discovered by Best and Banting in 1921 and then developed for use in human trials. The 21st Century organisation can build on this heritage in patient-focused discovery and development. Formerly the head of venture capital firm Primaxis, Ilse Treurnicht is chief executive of MaRS Discovery District. She acknowledges the crisis in venture capital funding, and says Canada's sector has always had less access funds through this route than other countries. This is one of the drivers behind the search for a new approach. Treurnicht says the old models of building biotech and life sciences businesses have to be discarded, as they have failed to build companies with critical mass. She says MaRS' new 'Convergence Innovation' strategy of bringing science, capital and business together will pay off.
  • "We call our strategy 'Convergence Innovation' and what we are trying to do is move away from the old linear model of academics struggling in their spare time to build companies or entrepreneurs doing this in a very incremental way."It takes time and it has many risk points along the way. So using this Convergence centre model to create a much more dynamic organisation which can help accelerate good ideas towards the commercialisation." But she says Canada's geography and demographics are always going to be a challenge. "This is a very large country with a small population. If you think in terms of clusters and hub regions, Canada's business hubs are separated geographically, and there is not much in between in terms of people."That means we can't try to be a little United States, because we just won't show up on the radar. We have to take a different approach. We have to think about collaboration as our potential competitive advantage - that means using networks and associations to solve problems and build businesses."So as new opportunities emerge, we can take them to market faster and hopefully with a higher success rate." The centre currently accommodates numerous start up companies, as well as those providing legal and financial services to them. AstraZeneca and GlaxoSmithKline also have offices on site. In all, MaRS provides mentoring for over 200 different companies across Ontario, and runs courses on entrepreneurship and preparing products for market.
  • ...7 more annotations...
  • Transition Therapeutics is one of the companies based at MaRS, and is an example of a biopharmaceutical company that is taking a new approach to the science and business of drug development.
  • Now Toronto's MaRS Innovation (MI) has been launched to try to guide and accelerate these promising ideas out of the wilderness and onto the market. MI is a not-for-profit technology transfer company that will channel all the best ideas to come out of Toronto's renowned academic centres. In the Toronto and Ontario area there were between 14-16 different technology transfer offices in the different institutions, and MaRS Innovation resolved to bring these interests together into a single entity after industry partners told them it was an inefficient way to do business. Bringing together the different institutions under one umbrella organisation has been an arduous task for MaRS, but the reward could be considerable for all parties. MI now oversees probably the largest intellectual property pipeline of its kind, representing about $1 billion in annual research spending. This means MI will be a unified route for all of Toronto's academics and their institutions when they want to develop and commercialise a bright idea. Most importantly, investors from industry who are looking to collaborate will now be able to deal with just organisation and one IP process. MI will cover patentable ideas across a broad range of areas, and not just life sciences - the discovery pipeline in physical sciences, information and communication technology, and green technology ('cleantech') will all be funnelled through MI. MI now represents three universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS Innovation, with support from MaRS and BioDiscovery Toronto, will advance commercialisation through industry partnerships, licensing and company creation.
  • ts chief executive is Dr Rafi Hofstein. Hofstein has been headhunted from Israel where he was chief executive of Hadasit, the technology transfer company of the Hadassah Medical Organization in Jerusalem and chair of the publicly-traded company Hadasit BioHolding. He brings this considerable experience in technology transfer to what he thinks is a groundbreaking enterprise."MaRS Innovation is a unique global initiative, and I must commend the institutional leaders in Toronto for pulling this innovation powerhouse together to strengthen commercialisation output." He adds: "I believe this is going to modernise the whole notion of tech transfer." He says the scale and diversity of MaRS Innovation's remit puts it into a league of its own. Other research clusters elsewhere in the world have attempted similar projects before, but have been thwarted by the difficulty in bringing parties together. MaRS Innovation will also help launch and grow new spin-off companies and incubate them for 2-3 years to ensure a strong commercial footing. Hofstein says MI will also fund proof of concept trials which will persuade major pharma companies to invest in their development.
  • MI has just announced its first two commercialisation deals with academic partners in the city. The first is with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital to develop stem cell from umbilical cords to treat cardiovascular disease, diabetes and neurological disorders. "With the Toronto area identified as a world-leading cluster in stem cell research, we are extremely excited to have identified this technology as our first commercialisation opportunity," said Dr Hofstein.
  • "Our partnership with MaRS Innovation on developing methods for using stem cells for diseases such as diabetes will allow us to work towards advancing care for these critical conditions."
  • The second collaboration is between MI and The University of Toronto (U of T) and involves a novel sustained release formulation of nitric oxide (NO) for applications in wound healing, including diabetic ulcers. "There are 300 million diabetics worldwide, of which some 15% develop troublesome foot ulcers. This wound healing technology is extremely exciting, making it an early commercialisation opportunity that MaRS Innovation has identified as being a potential win for some 45 million diabetics globally," said Dr Hofstein.
  • "This is one of many new commercialisation ventures that will be initiated by MaRS Innovation, our partner in commercialisation of research with 13 other academic institutions across the Greater Toronto Area," said Paul Young, U of T's vice-president, Research. "We at U of T are delighted that this innovation from Dr Lee will be taken to the marketplace to the benefit of society and the economy of Ontario and Canada." By aggregating the leading edge science of its institutional members and being a one-stop commercialisation centre for industry, entrepreneurs and investors, MI could really help put Toronto and Canada on the map."MaRS Innovation is deeply committed to facilitating strategic research collaborations with industry partners, strengthening the innovation capacity of Canadian industry through adoption of new technologies, and launching a new generation of robust, high-growth Canadian companies that will become global market leaders," added Dr Hofstein. "We look forward to working closely with all of our institutional members and to continue to jointly announce exciting commercial opportunities."
  • Assunta Krehl on 04 Aug 09
     
    Canada has always had to fight hard to attract talent and investment. As stated in Pharmafocus.com, "MaRS Discovery District helps to foster and accelerate the growth of successful Canadian businesses." MaRS Innovation has also been launched to accelerate ideas onto the market.
Assunta Krehl

Mount Sinai Services - 0 views

www.mountsinaiservices.com

Mount Sinai Services (MSS) Toronto Research Pharmaceutical

shared by Assunta Krehl on 29 Jul 09 - Cached
  • Mount Sinai Services (MSS) provides an extensive set of custom laboratory research services for researchers, pharmaceutical companies and other industry partners
  • Assunta Krehl on 29 Jul 09
     
    Mount Sinai Services (MSS) provides an extensive set of custom laboratory research services for researchers, pharmaceutical companies and other industry partners.
  • Assunta Krehl on 29 Jul 09
     
    Mount Sinai Services (MSS) provides an extensive set of custom laboratory research services for researchers, pharmaceutical companies and other industry partners
Assunta Krehl

I had loads of fun at the MaRS District Entrepreneurship VC interview (Ochard, iNovia &... - 0 views

chrisarsenault.blogspot.com/...s-of-fun-at-mars-district.html

raising capital Entrepreneurship 101

shared by Assunta Krehl on 13 Aug 09 - Cached
  • MaRS District Collaboration Centre in Toronto CIBC Presents Entrepreneurship 101. March 4th re-webcast of the session titled: How to Get Money From a VC Every entrepreneur wants to know the secrets for successfully pitching a VC or an angel. Join guest lecturer Peter Tolnai from Orchard Capital along with Chris Arsenault of iNovia Capital and Michael Midmer of Rosetta Capital, all prominent VCs who tell you their secrets for making a successful pitch.  They also host a Q&A session in which the panel  answers your questions directly without saying, "Come back in a few months when you've made some more revenue traction!"   http://www.marsdd.com/Events/Event-Calendar/Ent101/2009/what-investors-look-for-03042009.html
  • Last Wednesday I had the pleasure of participating in one of the MaRS District courses up in Toronto – CIBC Presents Entrepreneurship 101.
  • Assunta Krehl on 13 Aug 09
     
    Arsenault's blog mentions about Entrepreneurship101 presentation on How to Get Money From a VC by Peter Tolani from Orchard Capital along with Chris Arsenault of iNovia Capital and Michael Midmer of Rosetta Capital at the MaRS Centre. March 9, 2009
  • Assunta Krehl on 13 Aug 09
     
    Arsenault's blog mentions about Entrepreneurship101 presentation on How to Get Money From a VC by Peter Tolani from Orchard Capital along with Chris Arsenault of iNovia Capital and Michael Midmer of Rosetta Capital at the MaRS Centre.
Cathy Bogaart

Blogosphere on Bootstrapping - 1 views

www.sramanamitra.com/...n-bootstrapping-luke-timmerman

finance bootstrapping

shared by Cathy Bogaart on 11 Feb 10 - Cached
  • Cathy Bogaart on 11 Feb 10
     
    Sramana Mitra has put together a series on bootstrapping by surveying the blogosphere and collating the best pieces out there. Read her summaries and follow the links to the stories and articles for more detail. It includes a link to the MaRS Blog post, "Bootstrapping or "How to be a cheap b@st@rd"" by me, Cathy Bogaart.
Tim T

IAB Industry Data & Landscape - 0 views

www.iab.net/...947883

Advertising

shared by Tim T on 20 Dec 09 - Cached
  • Stay up to date with the latest data in interactive advertising with research and analysis from PricewaterhouseCoopers, Bain, Booz & Company and more.
  • Building Brands Online: An Interactive Advertising Action Plan from Bain & Company *NEW November 2009*
  • 2009 IAB Interactive Advertising Outlook Presentation
Assunta Krehl

Construction continues on MaRS Centre in Toronto - Daily Commercial News - August 15, 2012 - 0 views

www.dcnonl.com/id51469

MaRS Phase II Phase 2 PCL Constructors Canada B+H Architects

shared by Assunta Krehl on 17 Aug 12 - No Cached
  • Assunta Krehl on 17 Aug 12
     
    The MaRS Phase II project is expected to be completed in 2013. Currently, the window work is underway.
Assunta Krehl

Construction continues on the MaRS Centre Phase II in Toronto - Daily Commercial News -... - 0 views

dcnonl.com/...ars-centre-phase-ii-in-toronto

MaRS Phase 2 Phase II PCL Constructors Canada Inc B+H Architects

shared by Assunta Krehl on 16 May 12 - No Cached
  • Assunta Krehl on 16 May 12
     
    MaRS Discovery District Phase II Development is progressing well. PCL Constructors Canada Inc is a general contractor that is constructing a 21-storey building that will add one million square feet to the existing 750,000 square foot facility and is scheduled for completion for late 2013. 
1 - 20 of 21 Next ›
Showing 20▼ items per page